Biodexa Pharmaceuticals (MTPH) News Today → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free MTPH Stock Alerts GBX 18 -1.00 (-5.26%) (As of 03/27/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | americanbankingnews.comBiodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00April 26, 2024 | seekingalpha.comBiodexa shares rally 126% on rapamycin licensing dealMarch 28, 2024 | seekingalpha.comSLRX Salarius Pharmaceuticals, Inc.February 23, 2024 | msn.comBiodexa stock slides 7% amid data for two drug studiesFebruary 8, 2024 | markets.businessinsider.comBiodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma PatientsFebruary 7, 2024 | msn.comBiodexa stock jumps on allowance of U.S. patent covering TolimidoneFebruary 7, 2024 | tmcnet.comBiodexa Announces Allowance of U.S. Patent Covering TolimidoneDecember 19, 2023 | msn.comBiodexa Pharmaceuticals down 21%, prices equity offeringNovember 28, 2023 | msn.comWhat's Going On With Biodexa Pharmaceuticals Stock (BDRX) Today?November 27, 2023 | marketwatch.comBiodexa Enters Worldwide Licensing Deal for TolimidoneNovember 27, 2023 | msn.comBiodexa jumps on licensing deal for diabetes candidateNovember 27, 2023 | marketwatch.comBiodexa Pharma Shares Double After Licensing Deal for TolimidoneNovember 19, 2023 | morningstar.comBiodexa Pharmaceuticals Plc ADR BDRXOctober 3, 2023 | tmcnet.comBiodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent GlioblastomaJune 23, 2023 | msn.comBiodexa Pharmaceuticals announces ADR ratio changeMay 18, 2023 | technews.tmcnet.comBiodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian BiopharmaceuticalsApril 22, 2023 | investing.comBiodexa Pharmaceuticals PLC DRC (BDRX)April 3, 2023 | finance.yahoo.comBiodexa Pharmaceuticals PLC Announces Issue of Pre-Funded WarrantsMarch 28, 2023 | finance.yahoo.comBiodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of EquityMarch 27, 2023 | finance.yahoo.comMidatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal DiseaseMarch 24, 2023 | finance.yahoo.comMidatech Pharma PLC Announces Results of General MeetingMarch 10, 2023 | finance.yahoo.comMidatech Pharma PLC Announces Further re: Notice of General MeetingFebruary 15, 2023 | finance.yahoo.comMidatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker ChangeFebruary 9, 2023 | marketwatch.comMidatech Pharma to Raise About $6 Million to Develop Cancer TreatmentJanuary 6, 2023 | finance.yahoo.comMidatech Pharma PLC Announces Posting of Circular and Notice of General MeetingDecember 19, 2022 | finance.yahoo.comBioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plcDecember 19, 2022 | finance.yahoo.comMidatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & WebinarNovember 14, 2022 | finance.yahoo.comMidatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110October 18, 2022 | finance.yahoo.comMidatech Pharma PLC Announces Receipt of NASDAQ NotificationSeptember 14, 2022 | finance.yahoo.comMidatech Pharma PLC Announces Interim Results for the Six Months to 30 June 2022June 20, 2022 | finanznachrichten.deMidatech Pharma PLC Announces Directorate ChangeJune 1, 2022 | msn.comMidatech Pharma's Shares Shoot Higher On FDA Fast Track Designation For Malignant Brain Tumor DrugJune 1, 2022 | marketwatch.comMidatech Pharma Shares Rise on FDA Fast Track Designation for Cancer TreatmentJune 1, 2022 | finance.yahoo.comMidatech Pharma PLC Announces Fast Track Designation for MTX110 DevelopmentApril 26, 2022 | finance.yahoo.comMidatech Pharma PLC Announces Results for the Year Ended 31 December 2021March 9, 2022 | finance.yahoo.comMidatech Pharma PLC Announces R&D Collaboration with Janssen on Second MoleculeNovember 25, 2021 | markets.businessinsider.comMidatech Pharma PLC : Midatech presenting at the Shares/AJ Bell WebinarNovember 13, 2021 | finance.yahoo.comIs Midatech Pharma (LON:MTPH) In A Good Position To Invest In Growth?September 17, 2021 | marketwatch.comMidatech Pharma 1H Loss Narrowed Sharply Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter. Email Address 4 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 MTPH Media Mentions By Week MTPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MTPH News Sentiment▼0.670.51▲Average Medical News Sentiment MTPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MTPH Articles This Week▼10▲MTPH Articles Average Week Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: C4XD News SAR News OKYO News HEMO News AREC News OPTI News ONC News DEST News OBI News SNG News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:MTPH) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
